ArticleBMC pharmacology & toxicology2014

Cost analysis of voriconazole versus liposomal amphotericin B for primary therapy of invasive aspergillosis among patients with haematological disorders in Germany and Spain.

Helmut Ostermann et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.